T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUCK
2551
Lucky Strike Entertainment
LUCK
$942M
| $162K | ﹤0.01% |
16,805
+3,807
| +29% | +$41.9K |
|
2552
Quad
QUAD
$502M
| $161K | ﹤0.01% |
31,854
+216
| +0.7% | +$1.13K |
|
|
SGMO
2553
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $160K | ﹤0.01% |
265,113
+35,290
| +15% | +$37.8K |
|
2554
Perimeter Solutions
PRM
$5.67B
| $159K | ﹤0.01% |
34,923
+3,174
| +10% | +$17.7K |
|
|
KREF
2555
KKR Real Estate Finance Trust
KREF
$496M
| $158K | ﹤0.01% |
13,293
+1,833
| +16% | +$22.6K |
|
2556
GeneDx Holdings
WGS
$2.36B
| $158K | ﹤0.01% |
43,299
-453
| -1% | -$2.48K |
|
2557
Axogen
AXGN
$2.58B
| $157K | ﹤0.01% |
31,268
+9,504
| +44% | +$65.8K |
|
|
BGFV
2558
DELISTED
Big 5 Sporting Goods
BGFV
| $157K | ﹤0.01% |
22,377
+3,711
| +20% | +$30.9K |
|
2559
Mercer International
MERC
$34.1M
| $156K | ﹤0.01% |
18,123
+3,500
| +24% | +$30.2K |
|
2560
Cytek Biosciences
CTKB
$629M
| $155K | ﹤0.01% |
28,048
+3,304
| +13% | +$26.5K |
|
2561
PUT
Norwegian Cruise Line
NCLH
$8.82B
| $155K | ﹤0.01% |
9,400
| – | – |
|
2562
Life Time Group Holdings
LTH
$9.88B
| $154K | ﹤0.01% |
+10,093
| New | +$178K |
|
2563
MacroGenics
MGNX
$262M
| $154K | ﹤0.01% |
33,011
+8,034
| +32% | +$40K |
|
2564
PMV Pharmaceuticals
PMVP
$65.6M
| $154K | ﹤0.01% |
24,944
+983
| +4% | +$6.76K |
|
2565
UNIFI
UFI
$125M
| $153K | ﹤0.01% |
21,432
| – | – |
|
2566
The Joint Corp
JYNT
$121M
| $150K | ﹤0.01% |
16,627
+6,521
| +65% | +$73.7K |
|
|
DCPH
2567
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $150K | ﹤0.01% |
11,747
+1,414
| +14% | +$19.5K |
|
2568
Gevo
GEVO
$398M
| $148K | ﹤0.01% |
123,579
+32,622
| +36% | +$48.2K |
|
2569
Repay Holdings
RPAY
$308M
| $148K | ﹤0.01% |
19,298
+2,019
| +12% | +$16.8K |
|
2570
SES AI
SES
$211M
| $148K | ﹤0.01% |
65,135
+1,875
| +3% | +$4.55K |
|
2571
Unisys
UIS
$205M
| $147K | ﹤0.01% |
42,450
+677
| +2% | +$2.86K |
|
|
LUNA
2572
DELISTED
Luna Innovations Incorporated
LUNA
| $147K | ﹤0.01% |
25,062
+628
| +3% | +$4.75K |
|
2573
American Well
AMWL
$223M
| $146K | ﹤0.01% |
6,197
+250
| +4% | +$8.45K |
|
|
DX
2574
Dynex Capital
DX
$3.24B
| $146K | ﹤0.01% |
12,206
+1,585
| +15% | +$20.1K |
|
|
BAND
2575
Bandwidth Inc
BAND
$1.72B
| $145K | ﹤0.01% |
12,830
+769
| +6% | +$10.5K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.